v3.26.1
Strategic Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 31, 2022
Nov. 30, 2019
May 31, 2018
Apr. 30, 2018
Feb. 28, 2018
Mar. 31, 2017
Mar. 31, 2026
Dec. 31, 2023
Mar. 31, 2022
Jun. 30, 2026
Dec. 31, 2023
Dec. 31, 2021
Aug. 31, 2023
Upon Achievement of Specified Development and Regulatory Milestones | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   $ 50,000,000.0      
Microchips Biotech, Inc.                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Payment of additional consideration                   0   $ 1,250,000  
Microchips Biotech, Inc. | Upon Achievement of Specified Development and Regulatory Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments   $ 46,500,000                      
Current portion of contingent consideration   $ 55,000,000.0                      
ADVA Tec Agreement | Upon Achievement of Specified Development and Regulatory Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments           $ 14,600,000              
ADVA Tec Agreement | Maximum                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Percentage of royalty rate           10.00%              
ADVA Tec Agreement | Minimum                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Percentage of royalty rate           1.00%              
Douglas License Agreement | Upon Achieving Certain Development Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Sales based milestones amount                         $ 5,250,000
Douglas License Agreement | Upon Achieving Certain Commercial Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Sales based milestones amount                         $ 64,000,000.0
Hennepin License Agreement | Clinical and Regulatory Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments $ 6,250,000                        
Hennepin License Agreement | Sales Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments $ 45,000,000.0                        
Licensing Agreements | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   1,000,000.0      
Licensing Agreements | ADVA Tec Agreement | Upon Reaching Certain Worldwide Net Sales Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments           $ 20,000,000.0              
Licensing Agreements | Upon Achieving Certain Development Milestones | Maximum | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount               $ 500,000       300,000  
Licensing Agreements | Upon Achieving Certain Commercial Milestones | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   850,000      
Licensing Agreements | Upon Achieving Certain Commercial Milestones | Upon Achievement of Specified Development and Regulatory Milestones | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount           $ 1,200,000              
Licensing Agreements | Licensed Product or Process for Vaginal or Urological Use | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   250,000      
Assignment Agreement | Upon Achieving Certain Clinical and Regulatory Development Milestones | Related Party                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   1,100,000      
Merger Agreement                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments     $ 15,500,000                    
Milestone payments     3,200,000                    
Pear Tree Pharmaceuticals, Inc. | Sales Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments     $ 47,000,000.0                    
Juniper Pharmaceuticals, Inc                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Upfront license fee paid       $ 250,000                  
Potential annual license maintenance fee payments, thereafter       100,000                  
Juniper Pharmaceuticals, Inc | Clinical and Regulatory Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments       13,500,000                  
Juniper Pharmaceuticals, Inc | Sales Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Maximum potential milestone payments       $ 30,300,000                  
License and Collaboration Agreement                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount         $ 18,000,000.0                
License and Collaboration Agreement | Upon Achieving Certain Commercial Milestones                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount         $ 100,000,000.0   $ 1,000,000.0            
Organon                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Upfront license fee paid                 $ 10,000,000.0 12,800,000      
Sales based milestones amount                   $ 180,000,000.0      
Milestone payments, reimburse amount, PDUFA fees and other manufacturing expenses                     $ 1,000,000.0    
First commercial sale amount                     $ 1,800,000    
Advanced written notice period                   120 days      
Bayer | Royalty Revenue | Collaborative Arrangement                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Upfront license fee paid                   $ 1,000,000.0      
Former Stockholders of MBI | Microchips Biotech, Inc.                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Cash paid to stockholders' representative                       $ 75,000  
Catalent and MilanaPharm | Licensing Agreements                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments, contingent amount                   $ 1,000,000.0